Healthy ageing and immune concerns
Recurrent infections
Repeated infections can reflect exposure, airway disease, diabetes, immune problems or medicines. Frequent colds are not proof of an immune deficiency.
Potential benefits explored
More effective immune responses and fewer disruptive illnesses.
TA1, Thymogen and Thymalin offer distinct immune-modulation research directions. LL-37 adds antimicrobial biology; none should be treated as a universal immune booster.
Practical interpretation
Characterise infection sites, frequency and severity, assess contributing disease, and use appropriate prevention and infection-specific treatment.
Meaningful outcomes: Documented infection frequency, severity and recovery.
Compare the compounds studied for Recurrent infections
Members see the full evidence picture for this condition: every compound studied, graded per condition from strong human evidence through to preclinical-only and negative findings, with human and animal results, risks, combination evidence and cited sources — plus how each compound maps to the research materials we list, with live pricing and stock.
Research reference for laboratory materials only. Not medical advice and not a recommendation for human use. Research cut-off: 30 September 2026.